Researchers compared the current strain of Ebola, called EBOV/Mak, with two other strains of the virus — one from 1976 and one from 1995 — and found more than 600 genetic mutations in each comparison.
Additionally, researchers found 10 new mutations that might interfere with the mechanisms of the sequence-based drugs currently being evaluated, three of which have appeared during the current outbreak.
According to study authors, considering genetic drift is vital when developing possible Ebola treatments that will remain effective over time.
More articles on Ebola:
5 things healthcare leaders should know about the State of the Union address
12 things to know about the latest outbreaks, epidemics
Ebola, flu, measles: 7 latest stories on vaccines
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
